History of Awards
Grant Round 12 - October 2021
Optimization and Commercialization of Environmentally-Sustainable Biofungicides
Virginia Tech, University of Virginia AgroSpheres, Inc. (Charlottesville, VA) $600,000 Design Automation for Scaled Manufacturing of Advanced Custom Orthopedic Braces University of Virginia, Virginia Commonwealth University Icarus Medical Innovations (Charlottesville, VA) $600,000 Pilot Study to Evaluate a Nonsurgical Gel Patch for Eardrum Repair in Human Patients Eastern Virginia Medical School, Virginia Commonwealth University Tympanogen, Inc. (Richmond, VA) $737,369 |
Grant Round 11 - October 2020
Clinical Translation of a Male Contraceptive Procedure
University of Virginia, Virginia Commonwealth University Contraline, Inc. (Charlottesville, VA) $600,000 Treating Chronic Disease Caused by Microbiome Dysbiosis George Mason University, Eastern Virginia Medical School ISOThrive, Inc. (Manassas, VA) $800,000 Innovative Bioanalytical Instrument for Improving Drug Discovery Virginia Commonwealth University, Old Dominion University Meru Biotechnologies (Richmond, VA) $700,000 |
Grant Round 10 - January 2020
Microsystem for Label-Free Separation and Recovery of Tumor-Associated Cells
from Biopsies for Precision Medicine Virginia Tech, University of Virginia CytoRecovery Inc. (Blacksburg, VA) $400,000 Commercializing a Novel Treatment for Metastatic Cancers Virginia Commonwealth University, University of Virginia InterLeukin Combinatorial Therapies Inc. (Richmond, VA) $700,000 Design and Implementation of Green, Enzymatic Biofungicides for Pre- and Post-Harvest Crop Protection University of Virginia, Virginia Tech Lytos Technologies LLC (Charlottesville, VA) $500,000 Protein Painting of PD-1/PD-L1 for the Discovery of New Immune Checkpoint Inhibitors for the Treatment of Lung Cancer and Brain Metastasis George Mason University, Virginia Tech Monet Pharmaceuticals (Nokesville, VA) $400,000 Automated 3D Spinal Navigation System for Bedside Lumbar Puncture Procedures University of Virginia, Virginia Commonwealth University RIVANNA (Charlottesville, VA) $800,000 Development of an Applicator and Training Simulator for a Gel Patch for Nonsurgical Eardrum Repair Eastern Virginia Medical School, Virginia Commonwealth University Tympanogen (Richmond, VA) $500,000 |
Grant Round 9 - May 2019
Agrospheres-Enabled Biological Fungicide
Virginia Tech, University of Virginia AgroSpheres Inc. (Charlottesville, VA) $600,000 Rapid Drug Development Using Molecular Rotational Resonance (MRR) for Structure Analysis Virginia Commonwealth University, University of Virginia, Virginia Tech BrightSpec Inc. (Charlottesville, VA) $400,000 Nanotrap Liquid Biopsy Collection Device (LBC) for Cancer Diagnostics University of Virginia, George Mason University Ceres Nanosciences Inc. (Manassas, VA) $600,000 Implementation and Clinical Impact of a Next Generation Precision Oncology Platform University of Virginia, Eastern Virginia Medical School Perthera Inc. (McLean, VA) $500,000 |
Grant Round 8 - May 2018
MRR: A Major New Chiral Analysis Technique for Drug Discovery, Development and Process Control
Virginia Commonwealth University, Virginia Tech, University of Virginia BrightSpec Inc. (Charlottesville, VA) $400,000 Safe Mitochondrial Uncouplers for the Treatment of Human Disease Virginia Tech, University of Virginia Continuum Biosciences Inc. (Blacksburg, VA) $400,000 Biofabrication of Regenerative Musculoskeletal Therapeutics Old Dominion University, University of Virginia Embody Inc. (Norfolk, VA) $800,000 Tissue Preparations for Therapeutic Use in Cardiovascular Applications Old Dominion University, Eastern Virginia Medical School LifeNet Health (Virginia Beach, VA) $250,000 Novel Anti-Inflammatory Drug with Strong Neuroprotective Properties for Treatment of Traumatic Brain Injury (TBI) Virginia Commonwealth University, George Mason University Serpin Pharma (Manassas, VA) $350,000 Preventing Catheter Associated Infections Virginia Commonwealth University, University of Virginia WynnVision LLC (Richmond, VA) $510,000 |
Grant Round 7 - July 2017
Virginia Brain Injury Diagnosis and Monitoring Initiative
Virginia Tech, University of Virginia BRAINBox Solutions, Inc. (Richmond, VA) $500,000 Novel Preventive Treatment Paradigm to Change the Standard of Care for Those Who Recover from Opioid Overdose Virginia Commonwealth University, Virginia Tech, George Mason University/ Inova Indivior, Inc. (Richmond, VA) $500,000 Development of Peptide Inhibitor of Complement C1 as a treatment for neonatal hypoxic-ischemic encephalopathy Eastern Virginia Medical School, Virginia Commonwealth University ReAlta Life Sciences, Inc. (Norfolk, VA) $400,000 |
Grant Round 6 - October 2016
BT-11: First-in-class oral therapeutic for IBD
Virginia Tech, Virginia Commonwealth University BioTherapeutics, Inc. (Blacksburg, VA) VT, VCU $800,000 Bioengineering for the therapeutic delivery of massively expanded islet-derived human beta-cells Virginia Commonwealth University, University of Virginia Propagenix, Inc. (Rockville, MD) $425,000 Translational research with nanosecond pulsed electric fields for immuno-oncology applications Old Dominion University, Eastern Virginia Medical School Pulse Biosciences, Inc. (Burlingame, CA) $300,000 Accelerating the commercialization of the Diamond™ mouse model of NASH Eastern Virginia Medical School, George Mason University Sanyal Biotechnology (Richmond, VA) $100,000 Novel and potent anti-inflammatory drug with cardio-protective effects to treat myocardial injury and prevent heart failure George Mason University, Virginia Commonwealth University Serpin Parma (Manassas, VA) $400,000 Commercialization of INSPIRE brain cancer treatment Virginia Tech, University of Virginia VoltMed, Inc. (Blacksburg, VA) $800,000 |
Grant Round 5 - December 2015
Development of a biomarker assay and protocol for the commercialization of mibefradil dihydrochloride as a first-line treatment for glioblastoma
University of Virginia, George Mason University, Yale University Cavion, LLC (Charlottesville, VA) $307,057 INSPIRE to fight brain cancer Virginia Tech, University of Virginia VoltMed, Inc. (Blacksburg, VA) $380,000 |
Grant Round 4 - August 2015
Three wave mixing technique for chiral analysis in continuous process manufacturing
Virginia Commonwealth University, University of Virginia BrightSpec Inc. (Charlottesville, VA) $400,000 Optimizing oral delivery of BT-11 as a clinical candidate for treating inflammatory bowel disease Virginia Tech, Virginia Commonwealth University BioTherapeutics, Inc. (Blacksburg, VA) $400,000 Nanotrap® tick-panel test development George Mason University, Virginia Tech Ceres Nanosciences Inc. (Manassas, VA) $500,000 Nanofabrication of tissue scaffolds Old Dominion University, Eastern Virginia Medical School Embody, Inc. (Norfolk, VA) $634,500 Clinical trial of new drug in dogs to treat brain cancer in humans Virginia Tech, University of Virginia FirstString Research $290,000 |
Grant Round 3 - August 2014
PhenoCHIP-phenotype-based cell hierarchy and isolation platform
Virginia Tech, University of Virginia Proteo Biosciences $270,000 Biomarker-driven optimization of IL-12 gene electrotransfer for the treatment of melanoma Old Dominion University, Eastern Virginia Medical School Onosec Medical $585,000 Ultrasonographic probe Virginia Commonwealth University, Old Dominion University Ultrasonic Probe $536,000 |
Grant Round 2 - March 2014
Reversing bioenergetic deficits and improving cognitive function in Alzheimer’s Disease
Virginia Commonwealth University, University of Virginia Gencia Corporation $400,000 Enhancement of healing in diabetic wounds using a decellularized dermal matrix Eastern Virginia Medical School, University of Virginia LifeNet Health (Virginia Beach, VA) $255,000 UVA-VCU partnership to develop radioimmunotherapeutic and imaging agents to a unique cell-surface target relevant for multiple human cancers University of Virginia, Virginia Commonwealth University Neoantigenics $348,729 Lead optimization of a SphK2 inhibitor for the treatment of CKD Virginia Tech, University of Virginia SphynKx $400,000 |
Grant Round 1 - December 2013
Development of novel anti-inflammatory drugs
Virginia Tech, Virginia Commonwealth University BioTherapeutics, Inc. (Blacksburg, VA) $400,000 Commercialization of a human tumor microenvironment system for pharmaceutical cancer drug discovery and development University of Virginia, George Mason University HemoShear Therapeutics, Inc. (Charlottesville, VA) $450,000 Novel regenerative drug Virginia Tech, University of Virginia FirstString Research (Mount Pleasant, SC) $200,000 Determining the optimal dosing schedule for the commercialization of mibefradil in front-line glioblastoma University of Virginia, Virginia Commonwealth University Tau Therapeutics: now Cavion, LLC (Charlottesville, VA) $200,000 |